James P Zacny1, Melinda Drum. 1. Department of Anesthesia and Critical Care, The University of Chicago, 5841 South Maryland Avenue, Box MC 4028, Chicago, IL 60637, USA. jzacny@dacc.uchicago.edu
Abstract
BACKGROUND: Studies have shown that alcohol-drinking status modulates psychopharmacological effects of several drugs. We sought to determine if drinking status modulates the effects of a prescription opioid, oxycodone, in healthy volunteers. We included sex of the volunteer in the statistical analyses since this is a factor that is known to alter several pharmacodynamic effects of opioids in nonhumans and humans. METHODS:Fifteen light drinkers (eight males) and 14 moderate drinkers (eight males) participated in a crossover, randomized, double-blind study in which they received 0, 10, and 20mg of oxycodone (p.o.). Dependent measures were subjective, psychomotor/cognitive, reinforcing, and physiological effects. RESULTS: Self-reported alcohol-drinking status did not modulate the effects of oxycodone. However, there were a number of Sex x Dose interactions with females reporting more and larger unpleasant effects than males (e.g., visual analog scale ratings of "nauseated" greater in females than in males). CONCLUSIONS: Studies have established that moderate drinkers report a greater degree of abuse liability-related effects than do light drinkers with several different drugs, including diazepam, amphetamine, and nitrous oxide, but we were unable to establish this with the prescription opioid, oxycodone. However, we did observe sex differences in several subjective effects of oxycodone, a finding that is consistent with the extant literature showing sex differences in pharmacodynamic effects of opioids. Copyright 2009 Elsevier Ireland Ltd. All rights reserved.
RCT Entities:
BACKGROUND: Studies have shown that alcohol-drinking status modulates psychopharmacological effects of several drugs. We sought to determine if drinking status modulates the effects of a prescription opioid, oxycodone, in healthy volunteers. We included sex of the volunteer in the statistical analyses since this is a factor that is known to alter several pharmacodynamic effects of opioids in nonhumans and humans. METHODS: Fifteen light drinkers (eight males) and 14 moderate drinkers (eight males) participated in a crossover, randomized, double-blind study in which they received 0, 10, and 20mg of oxycodone (p.o.). Dependent measures were subjective, psychomotor/cognitive, reinforcing, and physiological effects. RESULTS: Self-reported alcohol-drinking status did not modulate the effects of oxycodone. However, there were a number of Sex x Dose interactions with females reporting more and larger unpleasant effects than males (e.g., visual analog scale ratings of "nauseated" greater in females than in males). CONCLUSIONS: Studies have established that moderate drinkers report a greater degree of abuse liability-related effects than do light drinkers with several different drugs, including diazepam, amphetamine, and nitrous oxide, but we were unable to establish this with the prescription opioid, oxycodone. However, we did observe sex differences in several subjective effects of oxycodone, a finding that is consistent with the extant literature showing sex differences in pharmacodynamic effects of opioids. Copyright 2009 Elsevier Ireland Ltd. All rights reserved.
Authors: Howard G Birnbaum; Alan G White; Jennifer L Reynolds; Paul E Greenberg; Mingliang Zhang; Sue Vallow; Jeff R Schein; Nathaniel P Katz Journal: Clin J Pain Date: 2006-10 Impact factor: 3.442
Authors: William W Stoops; Mark T Fillmore; Melania S Poonacha; Joe E Kingery; Craig R Rush Journal: Alcohol Clin Exp Res Date: 2003-05 Impact factor: 3.455
Authors: Maria Mavrikaki; Marco Pravetoni; Sarah Page; David Potter; Elena Chartoff Journal: Psychopharmacology (Berl) Date: 2017-01-27 Impact factor: 4.530
Authors: Monique M Cherrier; Danny D Shen; Laura Shireman; Andrew J Saxon; Tracy Simpson; Alex Men; Preetma Kooner; Gregory W Terman Journal: Pharmacol Biochem Behav Date: 2021-11-04 Impact factor: 3.533
Authors: Guilherme S Lopes; Suzette Bielinski; Ann M Moyer; Debra J Jacobson; Liwei Wang; Ruoxiang Jiang; Nicholas B Larson; Virginia M Miller; Ye Zhu; Dana C Cavanaugh; Jennifer St Sauver Journal: BMJ Open Date: 2021-06-30 Impact factor: 3.006